Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683020 · ClinicalTrials.gov registry record · NA
Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health Plan
A NA study of Diabetes, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 362
- Enrollment target
- 1
- Study location
NCT00683020: Completed NA study of Diabetes, sponsored by University of California, San Francisco.
NCT00683020 is a NA study of Diabetes that has completed, run by University of California, San Francisco. The registered enrollment target is 362 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00683020, a NA study of Diabetes, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 362 participants
- Enrollment target
- 1
- Study location
Study Summary
To measure the effects of a Medical health plan-directed automated telephone self-management support system (ATSM) on patient outcomes among ethnically diverse health plan enrollees with diabetes.
Primary Outcome
The SF-12 Health Survey (SF-12) is a 12-item short-form survey used to measure health status and monitor health outcomes. The survey asks about various health aspects, including physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health (psychological distress and psychological well-being). Two summary measures are derived: the Physical and the Mental Health Compo
Conditions Studied
Interventions
- BEHAVIORAL ATSM Intervention
Study Locations (1)
California
- Center for Vulnerable Populations - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 362 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-04 |
| Phase | NA |
What the finished NCT00683020 record still lists
NCT00683020 is an interventional study that assigns participants to a tested intervention. The registered 362 participants enrollment target is mid-sized for trials with a published cap, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which ATSM Intervention is the first listed.
NCT00683020 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00683020 about?
NCT00683020 is a clinical study titled "Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health Plan". To measure the effects of a Medical health plan-directed automated telephone self-management support system (ATSM) on patient outcomes among ethnically diverse health plan enrollees with diabetes.
What is the current status of trial NCT00683020?
This trial is currently completed. It is a NA study. The enrollment target is 362 participants. The study started on 2009-04. Estimated completion is 2012-04.
What conditions does trial NCT00683020 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT00683020?
The interventions under investigation include: ATSM Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00683020?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00683020 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00683020's enrollment target sits among peer trials
362 96th of 338 higher than 242 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
- NCT06472245 · 363 participants · Phase 3
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia